Applied Genetic Technologies Corporation

0.7350+0.1180+19.12%Vol 331.10K1Y Perf -85.02%
Jun 27th, 2022 16:00 DELAYED
BID0.7200 ASK0.7400
Open0.7252 Previous Close0.6170
Pre-Market- After-Market0.74
 - -  0.00 0.54%
Target Price
10.40 
Analyst Rating
Strong Buy 1.00
Potential %
1.31K 
Finscreener Ranking
★★     45.77
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     39.49
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
     34.74
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
3.87 
Earnings Rating
Strong Buy
Market Cap37.29M 
Earnings Date
16th May 2022
Alpha-0.02 Standard Deviation0.22
Beta1.65 

Today's Price Range

0.70000.7500

52W Range

0.58004.59

5 Year PE Ratio Range

-47.00575.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-9.93%
1 Month
-12.51%
3 Months
-35.53%
6 Months
-60.70%
1 Year
-85.02%
3 Years
-80.61%
5 Years
-85.87%
10 Years
-

TickerPriceChg.Chg.%
AGTC0.73500.118019.12
AAPL141.660.00000.00
GOOG2 332.45-38.3100-1.62
MSFT264.89-2.8100-1.05
XOM89.032.13002.45
WFC40.24-0.5200-1.28
JNJ182.12-0.1700-0.09
FB196.640.99000.51
GE66.71-0.2900-0.43
JPM116.38-0.9400-0.80
Financial StrengthValueIndustryS&P 500US Markets
2.60
2.70
0.23
0.52
-24.70
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
-
-12 441.20
-12 147.80
-390.70
-80.91
RevenueValueIndustryS&P 500US Markets
500.00K
0.01
-77.11
-62.39
Earnings HistoryEstimateReportedSurprise %
Q03 2022-0.42-0.3321.43
Q02 2022-0.38-0.45-18.42
Q01 2022-0.35-0.40-14.29
Q04 2021-0.37-0.2824.32
Q03 2021-0.41-0.402.44
Q02 2021-0.59-0.60-1.69
Q01 2021-0.51-0.60-17.65
Q04 2020-0.46-0.56-21.74
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.2730.77Positive
6/2022 FY-1.4413.25Positive
9/2022 QR-0.2548.98Positive
6/2023 FY-0.9523.39Positive
Next Report Date-
Estimated EPS Next Report-0.42
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume331.10K
Shares Outstanding50.73K
Shares Float50.60M
Trades Count1.61K
Dollar Volume242.37K
Avg. Volume375.44K
Avg. Weekly Volume401.77K
Avg. Monthly Volume242.14K
Avg. Quarterly Volume482.42K

Applied Genetic Technologies Corporation (NASDAQ: AGTC) stock closed at 0.735 per share at the end of the most recent trading day (a 19.12% change compared to the prior day closing price) with a volume of 331.10K shares and market capitalization of 37.29M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 83 people. Applied Genetic Technologies Corporation CEO is Susan B. Washer.

The one-year performance of Applied Genetic Technologies Corporation stock is -85.02%, while year-to-date (YTD) performance is -61.32%. AGTC stock has a five-year performance of -85.87%. Its 52-week range is between 0.58 and 4.59, which gives AGTC stock a 52-week price range ratio of 3.87%

Applied Genetic Technologies Corporation currently has a PE ratio of -0.40, a price-to-book (PB) ratio of 0.67, a price-to-sale (PS) ratio of 74.58, a price to cashflow ratio of 1.80, a PEG ratio of 2.32, a ROA of -59.81%, a ROC of -65.79% and a ROE of -90.45%. The company’s profit margin is -80.91%, its EBITDA margin is -12 147.80%, and its revenue ttm is $500.00 Thousand , which makes it $0.01 revenue per share.

Of the last four earnings reports from Applied Genetic Technologies Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.42 for the next earnings report. Applied Genetic Technologies Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Applied Genetic Technologies Corporation is Strong Buy (1), with a target price of $10.4, which is +1 314.97% compared to the current price. The earnings rating for Applied Genetic Technologies Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Applied Genetic Technologies Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Applied Genetic Technologies Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 14.93, ATR14 : 0.09, CCI20 : -231.52, Chaikin Money Flow : -0.11, MACD : -0.04, Money Flow Index : 47.52, ROC : -32.20, RSI : 28.33, STOCH (14,3) : 10.00, STOCH RSI : 0.00, UO : 40.88, Williams %R : -90.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Applied Genetic Technologies Corporation in the last 12-months were: Gerald Anthony Reynolds (Sold 3 994 shares of value $3 376 ), Susan B. Washer (Option Excercise at a value of $55 810), Susan B. Washer (Sold 9 950 shares of value $21 691 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
7 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Applied Genetic Technologies Corporation

Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 and ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology, and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight.

CEO: Susan B. Washer

Telephone: +1 386 462-2204

Address: 14193 NW 119th Terrace, Alachua 32615, FL, US

Number of employees: 83

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

Bearish Bullish

57%43%

TipRanks News for AGTC

Thu, 19 May 2022 08:05 GMT Analysts Are Bullish on These Healthcare Stocks: Applied Genetic Technologies (AGTC), Mersana Therapeutics (MRSN)

- TipRanks. All rights reserved.

Mon, 14 Feb 2022 16:50 GMT Applied Genetic Technologies (AGTC) Gets a Buy Rating from H.C. Wainwright

- TipRanks. All rights reserved.

Fri, 14 Jan 2022 09:11 GMT Applied Genetic Technologies (AGTC) Receives a Buy from Wells Fargo

- TipRanks. All rights reserved.

Tue, 11 Jan 2022 16:05 GMT Applied Genetic Technologies (AGTC) Receives a Buy from H.C. Wainwright

- TipRanks. All rights reserved.

News

Stocktwits